Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Drops By 63.9%

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 283,900 shares, a decline of 63.9% from the February 28th total of 787,200 shares. Currently, 2.8% of the company’s shares are short sold. Based on an average trading volume of 5,750,000 shares, the short-interest ratio is currently 0.0 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in GlucoTrack stock. XTX Topco Ltd bought a new position in shares of GlucoTrack, Inc. (NASDAQ:GCTK) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 85,394 shares of the company’s stock, valued at approximately $32,000. XTX Topco Ltd owned approximately 10.63% of GlucoTrack at the end of the most recent quarter. Hedge funds and other institutional investors own 10.92% of the company’s stock.

GlucoTrack Trading Down 11.8 %

GlucoTrack stock traded down $0.03 during trading on Friday, hitting $0.21. The company had a trading volume of 2,266,608 shares, compared to its average volume of 1,525,601. The stock has a market cap of $2.13 million, a price-to-earnings ratio of 0.00 and a beta of -0.29. GlucoTrack has a 1-year low of $0.16 and a 1-year high of $99.00. The company’s 50 day simple moving average is $0.74 and its 200-day simple moving average is $16.00.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.